A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients

计划入组 188 人 · 首次发布于 2020 年 1 月 7 日

A 12 Week, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee

计划入组 150 人 · 首次发布于 2013 年 6 月 7 日

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

计划入组 10,000 人 · 首次发布于 2019 年 2 月 22 日

Microbiome Platform

Win-64593

WIN-64745

IO Biotech

Denmark

European Thoracic Oncology Platform

Switzerland

Win-Medicare Pvt Ltd.

India

IO Biotech Explores Strategic Alternatives as Cancer Vaccine Developer Faces Financial Pressures

IO Biotech Unveils Promising Preclinical Data for Next-Generation Cancer Vaccines Targeting Tumor Microenvironment

IO Biotech's Cancer Vaccine Shows 25.5-Month Median Progression-Free Survival in Five-Year Melanoma Study